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Abstract: The objective of this work consisted in the assessment of 99mTc-ciprofloxacin imaging performance as a 
diagnostic tool in an experimental rat model of osteomyelitis. Bone (tibia) infection was induced in adult rats by 
inoculation of a suspension containing S. aureus suspended in fibrin glue. In vivo studies by means of small animal 
imaging were conducted using a gamma camera. The study shows the correlation between 99mTc-ciprofloxacin positive 
images with bacterial bone count but also with histopathological findings in an osteomyelitis animal model, highlighting 
its potential as a tool in preclinical research and the accomplishment of 3Rs concept regarding welfare of laboratory 
animals. 99mTc-MDP scintigraphy, failed to show these correlations and therefore it may be proposed as a 
complementary method to diagnose and follow up the bone physiopathology in this animal model. Future perspectives of 
small animal imaging in order to potentiate osteomyelitis basic research will derive from numerous research works, and 
99mTc-ciprofloxacin may still be a candidate for infectious diagnose and follow-up as demonstrated in this study. 
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INTRODUCTION 
For decades now, imaging techniques have been 
installed in clinical practice as a valuable tool for the 
diagnosis and therapeutic monitoring of different 
diseases. In the pre-clinical field, specifically in 
experimental animal models, these modalities are of 
more recent application [1, 2]. Osteomyelitis is an 
inflammation of bone caused by an invasive infection, 
occurring through direct inoculation of different kinds of 
pathogens such as viruses, parasites, fungi and 
bacteria, being the last one, the most common one. 
Osteomyelitis can occur after a trauma, by contiguous 
spreading of microorganisms from soft tissue 
infections, or via hematogenous seeding of microbes 
into bone tissue. Staphylococcus aureus (S. aureus) is 
the most common etiologic agent of osteomyelitis in 
both children and adults. This bacteria causes over 
90% of pediatric hematogenous osteomyelitis [3, 4]. 
In this sense, small animal imaging techniques have 
been proposed for monitoring bone remodeling during 
osteomyelitis caused by S. aureus [5]. Thus, the use of 
sensitive imaging techniques in laboratory animals 
would contribute to the development of experimental  
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models for the study of virulence factors, host immune 
responses and the evaluation of experimental 
treatments with increased statistical power and full 
compliance of the 3Rs [6]. The concept of the 3Rs is a 
humane way to implement work with laboratory animals 
discussed under the three broad headings of 
Replacement, Reduction, and Refinement. 
Replacement means the substitution of conscious living 
animals with senseless material. Reduction means 
using the lowest number of animals possible. 
Refinement means the absence of pain or stress and 
the use of less invasive techniques [5, 7]. 
In the diagnosis of osteoarticular infections, 99mTc-
ciprofloxacin has been proposed as a useful 
radiopharmaceutical however, it is unknown if 
preclinical research may benefit from its use as a probe 
for small animal imaging techniques [6, 8, 9]. 
Therefore, the objective of this work consisted in the 
assessment of 99mTc-ciprofloxacin imaging 
performance as a diagnostic tool in an experimental rat 
model of osteomyelitis. Additionally, the 99mTc-
metilendiphosphonate (99mTc-MDP) three phase 
imaging protocol was used for comparative purposes. 
MATERIAL AND METHODS 
Bacterial Isolate and Animal Model 
An isolate of S. aureus corresponding to the 
USA300 genotype was used. Bacteria were grown in 
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tripticase soy broth at 37oC with agitation over night. 
Bacteria were washed twice with phosphate-buffered 
saline (PBS) and the optical density at 600nm was 
adjusted to 1.5 in PBS. 
We used a rat model of osteomyelitis since bone 
infection was induced in Sprague Dawley rats (280-320 
g) as previously described [10] where each tibia was 
injected with a 5 µl suspension containing 1-2 x 106 
CFU (colony forming units) of S. aureus FRP3757 
corresponding to the USA300 genotype suspended in 
fibrin glue (Tissucol® kit 1 ml; Baxter Argentina-AG, 
Vienna, Austria). S aureus USA300 FPR3757 was 
kindly provided by Alice Prince (Columbia University, 
NY, USA). 
Radiolabeling Procedure of Imaging Agents and 
Small Imaging Protocol 
The imaging agents 99mTc-ciprofloxacin and 
99mTc-MDP were obtained by means of the 
radiolabelling of purchased cold kits (Laboratorios 
Bacon SAIC, Argentina) with Na99mTcO4 eluted from 
a 99Mo-99mTc generator (Laboratorios Bacon SAIC, 
Argentina) according to the methodology described by 
the manufacturer. Briefly, 3mL of the Na99mTcO4 
solution were added aseptically to the freeze-dried 
commercial kits in order to reach a final concentration 
of: 308MBq/mL for 99mTc-ciprofloxacin and 
962MBq/mL for 99mTc-MDP. After 10 minutes and 
mild agitation radiopharmaceuticals, radiochemical 
purity was assesed. Labeling efficiency exceeded 95% 
in all the assays performed. 
99mTc-ciprofloxacin and 99mTc-MDP were 
administered intravenously by the tail vein. Small 
animal imaging was performed in ventral position on 
the high resolution collimator of a small field of view 
gamma camera Ohio Nuclear. 99mTc-ciprofloxacin 
scintigraphy (37-74 MBq) was acquired as static 
imaging after 60 minutes of biodistribution (1.75 zoom) 
at 4 hours, 96 hours, 4 weeks, 10 weeks and 15 weeks 
after inoculation of bacteria. 99mTc-MDP (37-74 MBq) 
scintigraphic studies were performed at 96 hours and 
15 weeks after inoculation of bacteria in a three phase 
protocol. When positive scans were detected, a pinhole 
was further used for zoom images.  
Ex Vivo Determinations 
At the different time points evaluated some of the 
rats were euthanized using CO2. Left and right tibias 
were excised and evaluated morphometrically, and the 
osteomyelitic index (OI) was determined as described 
previously [10]. Briefly, the following measurements 
were made using calipers: (i) the distance between the 
inoculation point and the distal end of the left tibia (DT); 
(ii) the left tibia section diameter at the inoculation site 
(Di) and the perpendicular diameter at the same site 
(Dp); (iii) Di and Dp were also measured in the 
uninfected right tibia of the same rat at the DT 
determined in the diseased left tibia (control). The 
osteomyelitic index (OI) was determined as follows: OI 
= (Dp +Di) infected - (Dp +Di) control. The OI was 
determined by subtraction of values from the healthy 
right tibia (control). One-centimeter segments of bone 
involving the inoculation point were crushed, 
homogenized in sterile mortars and quantitatively 
cultured on Trypticase Soy Agar (TSA) plates to 
determine the bacterial load. 
Semiquantitative Analysis and Statistics 
Images were analyzed qualitatively and also 
quantitatively by means of drawing regions of interest 
(ROI) over the infected tibia and its counterpart as well 
as over the knees of both legs. Radioactivity uptake 
determined by means of counts in a ROI was 
expressed with a 95% confidence interval according to 
Poisson distribution. Ratios of radioactivity uptake 
between tibias (TR) in the same animal were calculated 
for each group and are showed as mean±standard 
deviation. The repeated-measures ANOVA model was 
used to evaluate differences among the images from 
different time points. The level of significance was set 
at P < 0.05. Correlation was analyzed with !  = 0.05 by 
means of the parametric test (Pearson) for TR vs OI 
and the non parametric test (Spearman) for TR vs 
CFU. 
RESULTS  
The ratio of 99mTc-ciprofloxacin uptake between 
tibias in the same animal was not significantly different 
among the time points evaluated (data not shown).  
A significant positive correlation between the 
number of CFU in the infected tibias and the 
radiopharmaceutical incorporation was observed at 15 
weeks after inoculation with S. aureus (r= 0.6565; p < 
0.05) (Figure 1, panel a). Similarly, a significant 
correlation (r = 0.7470; p < 0.05) was also found 
between 99mTc-ciprofloxacin uptake and the OI at 15 
weeks post bacterial challenge (Figure 1, panel b). 
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Figure 1: Panel A. Correlation between TR (radioactivity ratio 
between tibias) and number of viable bacteria at 15 weeks. 
Correlation parameters: correlation coefficient (r, Spearman); 
level of significance (p); number of XY pairs (n). Panel B. 
Correlation between TR (radioactivity ratio between tibias) 
and OI at 15 weeks (Osteomyelitic Index). Correlation 
parameters: correlation coefficient (r, Pearson); level of 
significance (p); number of XY pairs (n). 
Scintigraphy studies also showed focal uptake of 
99mTc-Ciprofloxacin in the infected tibias at random 
when OI values were under 1.5 while deliberate 
positive in cases where OI was higher than 1.5. These 
imaging findings were independent of the time of 
evolution of the animal model since focal uptake was 
detected in individuals of all time points evaluated as 
shown in the examples of Figure 2. 
99mTc-MDP three phase protocol showed positive 
scans at time point 96 hours compatible with bone 
damage and inflammatory reaction of the surgical 
procedure used to set up the experimental model 
(Figure 3). In this sense, images of the blood pool 
phase showed an increased and diffuse uptake of 
99mTc-MDP in the third means of the hind limb which 
correlates with a focal hot spot at the same level of the 
tibia in the delayed images.  
Images of the three phase scans at 15 weeks 
(Figure 3) showed an uptake pattern compatible with a 
bone remodeling profile after fractures, as compared 
with clinical setting in humans [11]. At this time point 
we observed a group of individuals with normal 
biodistribution of the radiopharmaceutical both at the 
blood pool images as well as in the delayed images 
while another group of animals showed a focal 
increased uptake in the blood pool images that 
remained, although less hot, in the delayed images. 
The uptake pattern showed the cortical diaphysis of the 
tibia as it can be verified in the images acquired with 
the pinhole collimator. Nevertheless, TR of 99mTc-
MDP scans did not correlate with either bacterial 
quantitative culture or the OI at 15 weeks post-bacterial 
challenge. 
DISCUSSION 
Representative animal models of osteomyelitis are 
valuable tools since they allow diagnostic and 
therapeutic research to keep moving forward [11]. 
 
Figure 2: Images from 99mTc-ciprofloxacin scintigraphy. Upper panel from left to right: reference image, 4hs and 96hs. Bottom 
panel: 4, 10 and 15 weeks. Focal 99mTc-ciprofloxacin uptake is shown with arrows. 
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Experimental handling of such animal models of 
infection diseases usually involves microbiological 
evaluation of the infected organ and searching for 
macro or micro changes in it such as bacterial 
colonization as well as morphological and 
histopathological changes [12-15]. The evaluation of 
these parameters is related, in a non negotiable way, to 
animal euthanasia which avoids the follow up of the 
same animal during the development of the disease or 
even worse, the follow up of a treatment using the 
same animal. Small animal imaging techniques 
contribute with the 3Rs concept in laboratory animal 
research [5] as well as with the improvement of the 
statistics of experimental designs [16]. In this work, we 
evaluated by means of small animal imaging 
techniques, the performance of a clinically available 
radiopharmaceutical as a diagnostic agent in an animal 
model of osteomyelitis. 
Our results show a correlation between 99mTc-
ciprofloxacin positive images evaluated as infected tibia 
/ non infected tibia uptake ratio not only with bacterial 
bone count but also with the osteomyelitic index, 
highlighting the potential of 99mTc-ciprofloxacin 
scintigraphy as a tool in preclinical research. In this 
study, the ratio of 99mTc-ciprofloxacin uptake between 
tibias did not change significantly along the time of 
evolution of the animal model. However, the 
remarkable finding was a significant positive correlation 
between the number of CFU in the infected tibias and 
the radiopharmaceutical incorporation at 15 weeks 
after inoculation with S. aureus as well as for the 
Osteomyelitic index. Scintigraphy studies also showed 
focal uptake, a main goal of imaging diagnosis, using 
99mTc-Ciprofloxacin in the infected tibias. These 
findings were at random when OI values were under 
1.5 while deliberately positive in cases where OI was 
higher than 1.5. This finding is in accordance with 
results reported by others [17]. Therefore, our results 
showed up that 99mTc-ciprofloxacin scintigraphy is a 
worthwhile tool in preclinical research to follow up 
those parameters without sacrificing the animal when 
using this experimental model. 
On the other hand, it is important to note that 
99mTc-MDP scintigraphy could not be correlated to ex 
vivo assessments. Although 99mTc-MDP is described 
as a high sensitivity tool for bone infectious diagnoses 
it lacks specificity because it also accumulates in bone 
areas of increased turnover [18-20]. In this way, 
99mTc-MDP three phase protocol showed the bone 
damage and the inflammatory reaction of the surgical 
 
Figure 3: Images from Two Phases 99mTc-MDP scintigraphy (blood pool and delayed bone images). 99mT-MDP images at 
4hs (t0) and 96hs 15 weeks. Left panels are blood pool images and right panels are delayed images. Focal uptake is shown 
with arrows and pinhole zoom with a circle. 
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procedure used to set up the experimental model. 
However, images of the three phase scans at 15 weeks 
showed an uptake pattern compatible with a bone 
remodeling profile after fractures, as compared with 
clinical setting in humans, instead of the focal uptake 
compatible with infection of 99mTc-Ciprofloxacin [18]. 
Moreover, TR of 99mTc-MDP scans did not correlate 
with either bacterial quantitative culture or the OI at 15 
weeks post-bacterial challenge and therefore it may be 
proposed as a complementary method to diagnose and 
follow up the bone pathophysiology in this animal 
model.  
It is noteworthy that TR calculated on 99mTc-
ciprofloxacin and 99mTc-MDP scans at time points of 
96 hours and 15 weeks were not significantly different. 
However, our results showed that 99mTc-MDP scan 
was not specific for infection diagnosis on the basis of 
our experimental design as was 99mTc-ciprofloxacin. 
Moreover, correlation with classical index of 
osteomyelitis diagnosis in this animal model was 
demonstrated. These findings could give notion on the 
ability of 99mTc-ciprofloxacin to differentiate 
inflammation, produced by the surgical trauma of 
bacteria inoculation for setting the experimental model, 
from installed infection in this particular animal model. 
This is a feature of 99mTc-ciprofloxacin that has been 
discussed in clinical researches [21-23] but not at the 
preclinical setting as far as the authors are concerned. 
CONCLUSION  
99mTc-ciprofloxacin imaging demonstrated to be a 
valuable diagnostic tool in our experimental rat model 
of osteomyelitis. 99mTc-ciprofloxacin provided 
functional information by using small animal imaging 
which correlated with the microbiological and 
histopathological features of our model and enhanced 
the accomplishment of 3Rs concept regarding welfare 
of laboratory animals. Future perspectives of small 
animal imaging in order to potentiate osteomyelitis 
basic research will derive from numerous research 
works, and 99mTc-ciprofloxacin may still be an 
interesting candidate for infectious diagnose and 
follow-up as demonstrated in this study. 
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